SCANCELL HLDGS (SCLP)
SCANCELL HLDGS (SCLP.L, LSE, LSE:SCLP)
SCLP Share PerformanceMore
|52 week high||45.240 01/06/15|
|52 week low||22.435 02/04/15|
|52 week change||-6.500 (-21.14%)|
|4 week volume||3,642,790 12/09/15|
Media for (SCLP)
Latest News« previous» nextMore
06/10/2015 - 07:00 RNS
RNS Number: 3054B Scancell Holdings Plc 06 October 2015 6 October 2015 Scancell Holdings Plc Six scientific presentations at the Progress in Vaccination against Cancer Conference highlight potential of ImmunoBody and Moditope platform technologies Scancell Holdings plc ('Scancell' or the 'Company'), the developer of novel immunotherapies for the treatment of c...
25/09/2015 - 15:20 Interactive Investor
The US personalised medicine market is tipped to be worth over $452 billion in 2015. These five British companies are fight...
18/09/2015 - 07:00 RNS
RNS Number: 4495Z Scancell Holdings Plc 18 September 2015 18 September 2015 Scancell Holdings Plc Final Results for the year ended 30 April 2015 Survival data for lead vaccine SCIB1 strengthens; new data demonstrates potential benefits of combining ImmunoBody vaccines with checkpoint inhibition Scancell Holdings plc, ('Scancell' or the 'Company') the developer...
16/09/2015 - 07:00 RNS
RNS Number: 1683Z Scancell Holdings Plc 16 September 2015 16 September 2015 Scancell Holdings Plc Scancell's ImmunoBody platform being presented at the Cancer Vaccines Conference, London Presentation entitled: ''Peptides or DNA vaccines? Could ImmunoBody be the answer?" Scancell Holdings plc ('Scancell' or the 'Company'), the developer of novel immunothe...
27/08/2015 - 16:42 RNS
RNS Number: 3587X Scancell Holdings Plc 27 August 2015 27 August 2015 Scancell Holdings Plc Notice of AGM Scancell Holdings plc ('Scancell' or the 'Company'), the developer of novel immunotherapies for the treatment of cancer, will host its Annual General Meeting on Tuesday 20 October 2015. AGM details are as follows: Date: Tuesday 20 October, 2015 Time: 11.00...
31/07/2015 - 00:00 BRR Media
30/07/2015 - 07:00 RNS
RNS Number: 5007U Scancell Holdings Plc 30 July 2015 Scancell and ImmunID announce collaboration to predict SCIB1 responders using ImmunTraCkeR Nottingham, UK and Grenoble, France, 30 July 2015 - Scancell Holdings plc ('Scancell' LSE:AIM SCLP), the developer of novel immunotherapies for the treatment of cancer, and ImmunID, an immune molecular ...
09/07/2015 - 07:32 StockMarketWire
Scancell Holdings has closed patient recruitment for its SCIB1 ImmunoBody Phase 1/2 clinical trial in patients with Stage II...
|Dividend yield||0 %|
Codes & Symbols
|Symbols||SCLP, LSE:SCLP, SCLP.L, SCLP:LN, LON:SCLP, XLON:SCLP|